Document:

EXHIBIT 10.1

THE SECURITIES REPRESENTED
HEREBY HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED HEREIN) PURSUANT TO REGULATION S
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). 

NONE OF THE SECURITIES REPRESENTED
HEREBY HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD,
DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION
S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933
ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT. 

SUBSCRIPTION
AGREEMENT

 

THIS SUBSCRIPTION AGREEMENT
(this “Agreement”), dated as of October 26, 2021, by and between LZG INTERNATIONAL, INC., a Florida corporation
(the “Company”), and the subscriber listed on the signature page hereof (the “Subscriber”).

 

WHEREAS, the Company and
Subscriber are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the provisions
of Section 4(2) and/or Regulation S (“Regulation S”) promulgated by the United States Securities and Exchange Commission
(the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”);

 

WHEREAS, the parties hereto
desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to Subscriber, and Subscriber
shall purchase the number of shares (the “Shares”) of common stock of the Company (the “Common Stock”)
set forth on the signature page.

 

NOW, THEREFORE, in consideration
of the mutual covenants and other agreements contained in this Agreement, the Company and Subscriber hereby agree as follows:

 

1.       Subscription
for Shares.

 

(a)       Subscription.
The Subscriber hereby irrevocably subscribes for and agrees to purchase the number of Shares as set out on page 16 of this Agreement at
a price of US$0.4545 per Share, for the total subscription price as set out on page 16 of this Agreement (the “Purchase Price”),
which Purchase Price is tendered herewith, on the basis of the representations and warranties and subject to the terms and conditions
set forth herein. The Company hereby agrees to sell, on the basis of the representations and warranties and subject to the terms and conditions
set forth herein, to the Subscriber the Shares, free of all liens, pledges, mortgages, security interests, charges, restrictions, adverse
claims or other encumbrances of any kind or nature whatsoever (“Encumbrances”), for the Purchase Price. Subject to
the terms hereof, the Agreement will be effective upon its acceptance by the Company. The Subscriber acknowledges and agrees that the
Company is effecting an increase in the number of shares of common stock to at least 250,000,000 pursuatn to Florida law, and subkect
ot the reporting reauirements of the Exchange Act (the “Share Increase”), and certificates for such shares shall not be issued
until the increase in authorized shares is effective pursuant to applicable state law. Notwithstanding the foregoing, any purchase price
delivered for a subscription hereby shall be delivered to the Company as set forth in Subsection (b) below and will be held, without interest,
pending the effectiveness of such increase in authorized shares. The Subscriber acknowledges and agrees that the Company shall effect
the acquisition of additional assets of FatBrain LLC and shall effect the conversion of certain outstanding convertible promissiory notes,
following (i) the execution of the first public trade of the Comapmny’s common stock on U.S. securiites markets (the “First
Trade”) and (ii) the Share Increase, such that following such asset purchase transaction, the total number of outstanding shares
of common stock will be approximately 110,000,000 shares. The price per share of common stock herein is based upon 110,000,000 shares
of common stock being outstanding, and a pre-trasanction Company valuation of $50,000,000.

 

(b)       Payment.
The Purchase Price must accompany this Agreement and shall be sent directly to the Company with the wireing coordinates set forth on Exhibit
A, which shall hold the funds until the Closing, at which time such funds shall become the property of the Company. The Parties further
acknowledge that there are no use of proceeds restrictions or provisions herein and the Purchase Price shall be used for general working
capital purposes as determined by the Company. Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful
money of the United States of America.

(c)       Documents
Required from Subscriber. The Subscriber must complete, sign and return to the Company one (1) executed copy of this Agreement. The
Subscriber shall complete, sign and return to the Company as soon as possible, on request by the Company, any documents, questionnaires,
notices and undertakings as may be required by regulatory authorities and applicable laws.

(d)       Closing.
Closing of the purchase and sale of the Shares shall occur on such date as may be determined by the Company in its sole discretion, provided
that such closing shall be within five (5) business days following the later of (i) the First Trade (ii) the Share Increase (the “Closing
Date”). The Subscriber acknowledges that Shares may be issued to other subscribers under this offering (the “Offering”)
before or after the Closing Date. The Subscriber acknowledges that the certificates representing the Shares will be available for delivery
within a reasonable time after Closing provided that the Subscriber has satisfied the requirements of Section 1(b) and (c) hereof and
the Company has accepted this Agreement.

2.       Acknowledgements
of Subscriber. The Subscriber acknowledges and agrees that:

 

(a) the Shares have not
been registered under the Securities Act of 1933, as amended (the “1933 Act”), or under any state securities or “blue
sky” laws of any state of the United States, and are being offered only in a transaction not involving any public offering within
the meaning of the 1933 Act, and, unless so registered, may not be offered or sold, directly or indirectly, in the United States or to
U.S. Persons (as defined herein), except in accordance with the provisions of Regulation S under the 1933 Act, pursuant to an effective
registration statement under the 1933 Act, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements
of the 1933 Act, and in each case only in accordance with applicable state securities laws;

 

(b) the Company has not
undertaken, and will have no obligation, to register any of the Shares under the 1933 Act;

 

(c) the Company will refuse
to register any transfer of the Shares not made in accordance with the provisions of Regulation S, pursuant to an effective registration
statement under the 1933 Act or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements
of the 1933 Act;

 

(d) by execution hereof
the Subscriber has waived the need for the Company to communicate its acceptance of the purchase of the Shares pursuant to this Agreement;

 

(e) the Company is entitled
to rely on the representations and warranties and the statements and answers of the Subscriber contained in this Agreement, and the Subscriber
will hold harmless the Company from any loss or damage it may suffer as a result of the Subscriber’s failure to correctly complete
this Agreement;

 

(f) the Subscriber has not
acquired the Shares as a result of, and will not itself engage in, any “directed selling efforts” (as defined in Regulation
S under the 1933 Act) in the United States in respect of any of the Shares which would include any activities undertaken for the purpose
of, or that could reasonably be expected to have the effect of, conditioning the market in the United States for the resale of any of
the Shares; provided, however, that the Subscriber may sell or otherwise dispose of any of the Shares pursuant to registration of any
of the Shares pursuant to the 1933 Act and any applicable state securities laws or under an exemption from such registration requirements
and as otherwise provided herein;

 

(g) the Subscriber understands
and agrees that offers and sales of any of the Shares prior to the expiration of the period specified in Regulation S (such period hereinafter
referred to as the “Distribution Compliance Period”) shall only be made in compliance with the safe harbor provisions set
forth in Regulation S, pursuant to the registration provisions of the 1933 Act or an exemption therefrom, and that all offers and sales
after the Distribution Compliance Period shall be made only in compliance with the registration provisions of the 1933 Act or an exemption
therefrom and in each case only in accordance with applicable securities laws;

 

(h) the statutory and regulatory
basis for the exemption claimed for the offer and sale of the Shares, although in technical compliance with Regulation S, would not be
available if the offering is part of a plan or scheme to evade the registration provisions of the 1933 Act or any applicable state securities
laws;

 

(i)Subscriber believes it
has received all the information it considers necessary or appropriate for deciding whether to invest in the Company and to accept the
Shares; Subscriber further represents that through its representatives it has had an opportunity to ask questions and receive answers
from the Company regarding the terms and conditions of the offering of the Shares and the business, properties and financial condition
of the Company and to obtain additional information (to the extent the Company possessed such information or could acquire it without
unreasonable effort or expense) necessary to verify the accuracy of any information furnished to it or to which it had access;

 

(j)        Reserved.

 

(k) the Subscriber has been
advised to consult the Subscriber’s own legal, tax and other advisors with respect to the merits and risks of an investment in the
Shares and with respect to applicable resale restrictions and the Subscriber is solely responsible (and the Company is not in any way
responsible) for compliance with applicable resale restrictions;

 

(l) the Company has advised
the Subscriber that the Company is relying on an exemption from the requirements to provide the Subscriber with a prospectus to sell the
Shares and, as a consequence of acquiring the Shares pursuant to such exemption certain protections, rights and remedies provided by the
applicable securities legislation will not be available to the Subscriber;

 

(m) neither the SEC nor
any other securities commission or similar regulatory authority has reviewed or passed on the merits of the Shares; no documents in connection
with this Offering have been reviewed by the SEC or any state securities administrators; there is no government or other insurance covering
any of the Shares;

 

(n)       Subscriber
has not taken, and will not take, directly or indirectly, any action designed to, or that might reasonably be expected to, cause or result
in stabilization or manipulation of the price of the Common Stock, to facilitate the sale or resale of the Shares or affect the price
at which the Shares may be issued or resold; and

 

(o) this Agreement is not
enforceable by the Subscriber unless it has been accepted by the Company, and the Subscriber acknowledges and agrees that the Company
reserves the right to reject any Agreement for any reason.

 

3.       Subscriber
Representations and Warranties. Subscriber hereby represents and warrants to and agrees with the Company that:

 

(a)       Standing
of Subscriber. Subscriber has the legal capacity and power to enter into this Agreement. If Subscriber is an entity, such Subscriber
is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation. If Subscriber is a natural
person, such Subscriber is not a minor and has the legal capacity to enter into this Agreement.

 

(b)       Authorization
and Power. Subscriber has the requisite power and authority to enter into and perform this Agreement and to pay the Purchase Price
and accept the Shares. The execution, delivery and performance of this Agreement by Subscriber and, if Subscriber is an entity, the consummation
by Subscriber of the transactions contemplated hereby have been duly authorized by all necessary company action, and no further consent
or authorization of Subscriber, its board of directors or similar governing body, or stockholders is required, as applicable. This Agreement
has been duly authorized, executed and delivered by Subscriber and constitutes, or shall constitute when executed and delivered, a valid
and binding obligation of Subscriber, enforceable against Subscriber in accordance with the terms thereof.

 

(c)       Foreign
Person Status.

 

(i)The Subscriber is not
a U.S. Person;

 

(ii)        the
Subscriber is not acquiring the Shares for the account or benefit of, directly or indirectly, any U.S. Person;

 

(iii)        the
Subscriber is resident in the jurisdiction set out on page 12 of this Agreement; and

 

(iv)        the
issuance of the Shares to the Subscriber as contemplated by the delivery of this Agreement, the acceptance of it by the Company and the
issuance of the Shares to the Subscriber complies with all applicable laws of the Subscriber’s jurisdiction of residence or domicile
and will not cause the Company to become subject to or comply with any disclosure, prospectus or reporting requirements under any such
applicable laws.

 

(e)        Applicable
Local Law. The Subscriber:

 

(i) is knowledgeable of,
or has been independently advised as to, the applicable securities laws of the securities regulators having application in the jurisdiction
in which the Subscriber is resident (the “International Jurisdiction”) which would apply to the acquisition of the
Shares;

 

(ii) is purchasing the
Shares pursuant to exemptions from prospectus or equivalent requirements under applicable securities laws or, if such is not applicable,
the Subscriber is permitted to purchase the Shares under the applicable securities laws of the securities regulators in the International
Jurisdiction without the need to rely on any exemptions;

 

(iii) acknowledges that
the applicable securities laws of the authorities in the International Jurisdiction do not require the Company to make any filings or
seek any approvals of any kind whatsoever from any securities regulator of any kind whatsoever in the International Jurisdiction in connection
with the issue and sale or resale of the Shares; and

 

(iv) represents and warrants
that the acquisition of the Shares by the Subscriber does not trigger:

  

A. any obligation to prepare
and file a prospectus or similar document, or any other report with respect to such purchase in the International Jurisdiction, or

  

0 B. any continuous disclosure
reporting obligation of the Company in the International Jurisdiction, and

  

C.the Subscriber will,
if requested by the Company, deliver to the Company a certificate or opinion of local counsel from the International Jurisdiction which
will confirm the matters referred to herein to the satisfaction of the Company, acting reasonably.

 

(f)        Investment
Representations.

 

(i)       The
Subscriber is acquiring the Shares as principal for investment only and not with a view to, or for, resale, distribution or fractionalization
thereof, in whole or in part, and, in particular, it has no intention to distribute either directly or indirectly any of the Shares in
the United States or to U.S. Persons;

 

(ii) the Subscriber is
outside the United States when receiving and executing this Agreement;

 

(iii) the Subscriber has
received and carefully read this Agreement;

 

(iv) the Subscriber understands
and agrees not to engage in any hedging transactions involving any of the Shares unless such transactions are in compliance with the provisions
of the 1933 Act and in each case only in accordance with applicable state securities laws;

 

(v) the Subscriber acknowledges
that it has not acquired the Shares as a result of, and will not itself engage in, any “directed selling efforts” (as defined
in Regulation S under the 1933 Act) in the United States in respect of any of the Shares which would include any activities undertaken
for the purpose of, or that could reasonably be expected to have the effect of, conditioning the market in the United States for the resale
of any of the Shares; provided, however, that the Subscriber may sell or otherwise dispose of any of the Shares pursuant to registration
of any of the Shares pursuant to the 1933 Act and any applicable state securities laws or under an exemption from such registration requirements
and as otherwise provided herein;

 

(vi)the Subscriber (i)
has adequate net worth and means of providing for the Subscriber’s current financial needs and possible personal contingencies,
(ii) has no need for liquidity in this investment, and (iii) is able to bear the economic risks of an investment in the Shares for an
indefinite period of time, and can afford the complete loss of such investment;

 

(vii) the Subscriber has
the requisite knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of the investment
in the Shares and the Company, and the Subscriber is providing evidence of knowledge and experience in these matters through the information
contained in this Agreement;

 

(viii)the Subscriber is
aware that an investment in the Company is speculative and involves certain risks, including the possible loss of the investment;

 

(ix) the entering into
of this Agreement and the transactions contemplated hereby do not result in the violation of any of the terms and provisions of any law
applicable to, or, if applicable, the governing documents of, the Subscriber, or of any agreement, written or oral, to which the Subscriber
may be a party or by which the Subscriber is or may be bound;

 

(x) all information contained
in this Agreement is complete and accurate and may be relied upon by the Company, and the Subscriber will notify the Company immediately
of any material change in any such information occurring prior to the Closing Date;

 

(xi) the Subscriber understands
and agrees that offers and sales of any of the Shares prior to the expiration of the period specified in Regulation S (such period hereinafter
referred to as the “Distribution Compliance Period”) shall only be made in compliance with the safe harbor provisions
set forth in Regulation S, pursuant to the registration provisions of the 1933 Act or an exemption therefrom, and that all offers and
sales after the Distribution Compliance Period shall be made only in compliance with the registration provisions of the 1933 Act or an
exemption therefrom and in each case only in accordance with applicable state securities laws;

 

(xii) the Subscriber is
purchasing the Shares for its own account for investment purposes only and not for the account of any other person and not for distribution,
assignment or resale to others, and no other person has a direct or indirect beneficial interest is such Shares, and the Subscriber has
not subdivided his interest in the Shares with any other person;

 

(xiii) the Subscriber
is not an underwriter of, or dealer in, the shares of the Company’s common stock, nor is the Subscriber participating, pursuant
to a contractual agreement or otherwise, in the distribution of the Shares;

 

(xiv) the Subscriber has
made an independent examination and investigation of an investment in the Shares and the Company and has depended on the advice of the
Subscriber’s legal and financial advisors and agrees that the Company will not be responsible in anyway whatsoever for the Subscriber’s
decision to invest in the Shares and the Company;

 

(xv) if the Subscriber
is acquiring the Shares as a fiduciary or agent for one or more investor accounts, the Subscriber has sole investment discretion with
respect to each such account, and the Subscriber has full power to make the foregoing acknowledgements, representations and agreements
on behalf of such account;

 

In this Agreement, the term “U.S. Person”
shall have the meaning ascribed thereto in Regulation S promulgated under the 1933 Act and for the purpose of the Agreement includes any
person in the United States.

 

(g)       Share
Legend. The Shares shall bear the following or similar legend:

“THE SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED
HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”).

 

NONE OF THE SECURITIES REPRESENTED HEREBY
HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY
OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER
THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED
STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT.”

 

4.       Company
Representations and Warranties. The Company represents and warrants to, and agrees with, Subscriber that:

 

(a)       Due
Incorporation. The Company is a corporation duly organized and in good standing under the laws of Florida;

 

(b)       Authority;
Enforceability. This Agreement has been duly authorized, executed and delivered by the Company and are the valid and binding agreements
of the Company, enforceable in accordance with their terms, except as may be limited by bankruptcy, insolvency, moratorium or other similar
laws affecting the enforcement of creditors’ rights generally, or principles of equity. The Company has full power and authority
necessary to enter into and deliver this Agreement and to perform its obligations hereunder;

 

(c)       Company
Capitalization and Voting Rights.  The Company’s capitalization is set forth on Schedule 5(c) hereto. All of the outstanding
shares of the Common Stock are duly authorized and validly issued, fully paid and non-assessable and are not (and will not be) subject
to preemptive or similar rights affecting the Common Stock. As of the date hereof, except as described in the Company SEC Documents (as
defined below), there are no (i) contracts to which the Company is a party obligating the Company to accelerate the vesting of any company
equity award as a result of the transactions contemplated by this Agreement (whether alone or upon the occurrence of any additional or
subsequent events), (ii) outstanding securities of the Company convertible into or exchangeable for shares of the Common Stock, (iii)
outstanding options, warrants or other agreements or commitments to acquire from the Company, or obligations of the Company to issue,
shares of capital stock of (or securities convertible into or exchangeable for shares of capital stock of) the Company or (iv) restricted
shares, restricted stock units, stock appreciation rights, performance shares, profit participation rights, contingent value rights, “phantom”
stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value
or price of, any shares of capital stock of the Company, in each case that have been issued by the Company (the items in clauses (i),
(ii) and (iii), together with the capital stock of the Company, being referred to collectively as “Company Securities”). There
are no outstanding contracts requiring the Company to repurchase, redeem or otherwise acquire any Company Securities and the Company is
not a party to any voting agreement with respect to any Company Securities;

 

(d)       SEC
Filings; Financial Statements; Absence of Certain Changes.

(i)       SEC
Filings. The Company has filed with the SEC all registration statements, prospectuses, reports, schedules, forms, statements and other
documents (including exhibits and all other information incorporated by reference) required to be filed or furnished by it with the SEC
since its inception (the “Company SEC Documents”) and such Company SEC Documents when filed were true, correct and
complete in all material respects. As of their respective filing dates (or, if amended or superseded by a subsequent filing, as of the
date of the last such amendment or superseding filing prior to the date hereof), each of the Company SEC Documents complied in all material
respects with the applicable requirements of the Sarbanes-Oxley Act of 2002 (including the rules and regulations promulgated thereunder)
and the Exchange Act, and the rules and regulations of the SEC thereunder applicable to such Company SEC Documents and did not, at the
time it was filed (or, if amended, at the time (and taking into account the content) of such amendment), contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading;

 

(ii)       Financial
Statements. Each of the consolidated financial statements (including, in each case, any related notes thereto) contained in the Company
SEC Documents: (i) complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto
as of their respective dates; (ii) was prepared in accordance with United States generally accepted accounting principles (“GAAP”)
applied on a consistent basis throughout the periods involved (except as may be indicated in the notes thereto and, in the case of unaudited
interim financial statements, as may be permitted by the SEC for Quarterly Reports on Form 10- Q); and (iii) fairly presented in all material
respects the consolidated financial position of the Company at the respective dates thereof and the consolidated results of the Company’s
operations and cash flows for the periods indicated therein, subject, in the case of unaudited interim financial statements, to normal
and year-end audit adjustments as permitted by GAAP and the applicable rules and regulations of the SEC;

 

(iii)Absence of Certain Changes. Neither
the Company nor any of its subsidiaries has any liability, indebtedness or obligation of any kind (whether accrued, absolute, contingent,
matured, unmatured or otherwise, and whether or not required to be recorded or reflected on a balance sheet under GAAP) (“Liability”)
except for Liabilities that (a) are reflected or recorded on the Company’s most recent balance sheet included in the Company SEC
Documents (including in the notes thereto but only to the extent it is reasonably apparent that the disclosure in such notes is of a Liability
required to be reflected on a balance sheet prepared in accordance with GAAP) contained in the Company SEC Documents or (b) are current
Liabilities (within the meaning of GAAP) which were incurred since the date of such balance sheet in the ordinary course of business consistent
with past practice;

 

(e)Related Party Transactions.All
contracts, transactions, arrangements and understandings with any executive officer or director of the Company or any of its subsidiaries,
any other person that directly or indirectly controls, is controlled by or is under common control with (“Affiliate”),
the Company, or any person owning 5% or more of the shares of the Common Stock (or any of such person's immediate family members or Affiliates
or associates), which is required to be disclosed under Item 404 of Regulation S-K promulgated under the Securities Act, have been fully
and properly disclosed in the appropriate Company SEC Documents. There are no such contracts, transactions, arrangements or understandings
which have not been so disclosed;

 

(f)       Consents.
No consent, approval, authorization or order of any court, governmental agency or body having jurisdiction over the Company or of any
other person is required for the execution by the Company of this Agreement and compliance and performance by the Company of its obligations
hereunder including, without limitation, the issuance of the Shares;

 

(g)       No
Violation or Conflict. Neither the issuance and sale of the Shares nor the performance of the Company’s obligations under this
Agreement will:

 

(i)       violate,
conflict with, result in a breach of, or constitute a default (or an event which with the giving of notice or the lapse of time or both
would be reasonably likely to constitute a default) under (a) the charter or bylaws of the Company or (b) any decree, judgment, order
or determination applicable to the Company of any court, governmental agency or body having jurisdiction over the Company or over the
properties or assets of the Company or (c) any contract, agreement, instrument or undertaking to which the Company or any subsidiary is
a party; or

 

(ii)       result
in the creation or imposition of any lien, charge or encumbrance upon the Shares except in favor of Subscriber as described herein;

 

(h)       Legal
Proceedings. As of the date of this Agreement, there is no legal, administrative, investigatory, regulatory or similar action, suit,
claim or proceeding which is pending or threatened against the Company which, if determined adversely to the Company, could have, individually
or in the aggregate, a Material Adverse Effect.

 

(i)       No
Liens. The Shares:

 

(i)       shall
be free and clear of any security interests, liens, claims or other Encumbrances, subject only to restrictions upon transfer under the
Securities Act and any applicable state securities laws;

 

(ii)       shall
have been duly and validly issued, fully paid and non-assessable; and

 

(iii)       will
not subject the holders thereof to personal liability by reason of being such holders;

 

(j)       No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person or entity acting on its or their behalf, has
engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or sale of the Shares;

 

(k)       Investment
Company. The Company is not an “investment company” within the meaning of the Investment Company Act of 1940, as amended;

 

(l)       Listing
and Maintenance Requirements. The Company is, and has no reason to believe that it will not in the foreseeable future continue to
be, in compliance with the listing and maintenance requirements for continued listing or quotation of the Company Common Stock on the
trading market on which the Company Common Stock is currently listed or quoted. The issuance and sale of the Shares under this Agreement
does not contravene the rules and regulations of the trading market on which the Company Common Stock is currently listed or quoted, and
no approval of the stockholders of the Company is required for the Company to issue and deliver to the Subscribers the Shares contemplated
by this Agreement; and

 

(m)       Full
Disclosure. No representation or warranty or other statement made by the Company in this Agreement in connection with the contemplated
transactions contains any untrue statement of material fact or omits to state a material fact necessary to make the representations and
warranties set forth herein, in light of the circumstances in which they were made, not misleading.

 

5.       Non-Public
Information. While the Shares are held by the Subscriber, the Company covenants and agrees that neither it nor any other person acting
on its behalf will at any time provide the Subscriber with any information that the Company believes constitutes material non-public information.
The Company understands and confirms that the Subscriber shall be relying on the foregoing representations in effecting transactions in
securities of the Company.

 

6.       Broker’s
Commission/Finder’s Fee. Each party hereto represents to the other that there are no parties entitled to receive fees, commissions,
finder’s fees, due diligence fees or similar payments in connection with the consummation of the transactions contemplated hereby.
Each party hereto agrees to indemnify the other against and hold the other harmless from any and all liabilities to any persons claiming
brokerage commissions or similar fees on account of services purported to have been rendered on behalf of the indemnifying party in connection
with this Agreement or the transactions contemplated hereby and arising out of the indemnifying party’s actions.

 

7.       Covenants
Regarding Indemnification. Each party hereto agrees to indemnify, hold harmless, reimburse and defend the other party and the other
party’s officers, directors, agents, counsel, affiliates, members, managers, control persons, and principal shareholders, as applicable,
against any claim, cost, expense, liability, obligation, loss or damage (including reasonable legal fees) of any nature, incurred by or
imposed upon the indemnified party or any such person which results, arises out of or is based upon (i) any breach of any representation
or warranty by the indemnifying party in this Agreement or (ii) any breach or default in performance by the indemnifying party of any
covenant or undertaking to be performed by the indemnifying party.

 

8.       Reporting
Status. As soon as practicable after the consummation of the sale of Shares hereby, and until the date on which the Subscriber shall
have sold all of the Shares, the Company shall use its reasonable best efforts to timely file all reports required to be filed with the
SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an issuer required to file reports under the Exchange
Act.

 

9.       Miscellaneous.

 

(a)       Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt
requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery
or facsimile, addressed as set forth in the preamble paragraph hereto or to such other address as such party shall have specified most
recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a)
upon hand delivery at the address designated in the preamble paragraph hereto (if delivered on a business day during normal business hours
where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during
normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express
courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

 

(b)       Entire
Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and
may be amended only by a writing executed by both parties hereto. Neither the Company nor Subscriber has relied on any representations
not contained or referred to in this Agreement and the documents delivered herewith.

 

(c)       Counterparts/Execution.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts, each of
which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument. This
Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means with the same force and
effect as if such signature page were an original thereof.

 

(d)       Law
Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State of Pennsylvania
without regard to principles of conflicts of laws. Any action brought by either party hereto against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of Pennsylvania or in the federal courts located in the State
of Pennsylvania. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. EACH PARTY HERETO
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

 

(e)       Severability.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith
and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law.

 

(f)       Counsel;
Ambiguities. Each party and its counsel have participated fully in the review and revision of this Agreement. The parties understand
and agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not apply in
interpreting this Agreement. The language in this Agreement shall be interpreted as to its fair meaning and not strictly for or against
any party.

 

(g)       Captions.
The captions of the various sections and paragraphs of this Agreement have been inserted only for the purposes of convenience; such captions
are not a part of this Agreement and shall not be deemed in any manner to modify, explain, enlarge or restrict any of the provisions of
this Agreement.

 

 

[signature page follows]

    	 

    	 

    

SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT

 

IN WITNESS WHEREOF, the parties has caused this
Agreement to be executed on and as of the date set forth above.

 

LZG INTERNATIONAL, INC.

 

 

By: ______________________________

Name: Peter Ritz

Title: Chief Executive Officer

 

 

	SUBSCRIBER:
	
     

    Name of Subscriber:

     

    _________________________________________

     

    Address:

     

    _________________________________________

    _________________________________________

     

    Fax No.: _________________________________

     

    Taxpayer ID# (if applicable): _________________

     

    _________________________________________

    (Signature)

     

    By: _____________________________________

     

    Dated: ________ ___, 2021

     

    Number of Shares: _____________ (___________)

    Aggregate Purchase Price:

    ______________ US Dollars ($___________)

[Signature Page
to LZG International, Inc. Subscription Agreement]

 

    	 

    	 

    

Schedule 5(c)

 

Company Capitalization

 

The Company has 100,000,000 shares of Common Stock
authorized for issuance under Florida law. As of the date hereof, there are approximately 10,250,256 million shares of the Common Stock
issued and outstanding, and approximately 10,00,000 shares of Common Stock that may be issued hereafter in respect of convertible securities
issued and outstanding as of the date hereof.Exhibit
4.4

 

WARRANT
AGREEMENT

 

This
WARRANT AGREEMENT (this “Agreement”) is made as of [●], 2021 between Genesis Unicorn Capital Corp., a Delaware
corporation, with offices at 281 Witherspoon Street, Suite 120, Princeton, NJ, 08540 (the “Company”), and Continental
Stock Transfer & Trust Company, a New York limited purpose trust company, with offices at 1 State Street, New York, New York 10004,
as warrant agent (“Warrant Agent”).

 

WHEREAS,
the Company is engaged in a public offering under the Securities Act of 1933, as amended (“Public Offering”) of up
to 8,625,000 units (including 1,125,000 units which may be issued pursuant to an overallotment option granted to the underwriters
of the Public Offering), each unit (the “Public Units”) comprised of one share of Class A common stock, par value,
$0.001 per share (“Share” and collectively. “Shares”) and three-fourths of one redeemable warrant to
purchase one share of Common Stock, where each whole warrant entitles the holder to purchase one Share at a price of $11.50 per share,
subject to adjustment as described herein, and, in connection therewith, will issue and deliver up to 6,468,750 warrants (the
“Public Warrants”) to the public investors in connection with the Public Offering; and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-1,
No. 333-______ (“Registration Statement”) and prospectus (“Prospectus”), for the registration,
under the Securities Act of 1933, as amended (“Act”) of, among other securities, the Units, Shares and Public Warrants;
and

 

WHEREAS,
the Company has a received binding commitments (“Subscription Agreements”) from the Company’s sponsor, Genesis
Unicorn Capital, LLC (the “Sponsor”), to purchase, simultaneously with the closing of the Public Offering, up to an
aggregate of 379, 925 units (the “Private Units”), each containing one Share and three fourths of one warrant
to acquire  one Share ( “Private Warrants”), each exercisable to purchase one Share at a price of $11.50 per share,
bearing the legend set forth in Exhibit B hereto; and

 

WHEREAS,
the Company may issue up to an additional 150,000 units (the “Working Capital Units” and together with the Public
Units and the Private Units, the “Units”) at a price of $10.00 per Working Capital Unit, with each Working Capital
Unit consisting of one Share and three fourths of one warrant to acquire   a Share (a whole warrant of each such warrant, a
“Working Capital Warrant”), in satisfaction of certain working capital loans made by the Company’s Sponsor,
officers, directors, initial stockholders and their affiliates; and

 

WHEREAS,
following consummation of the Public Offering, the Company may issue additional warrants (“Post IPO Warrants” and
together with the Public Warrants, Private Warrants, and Working Capital Warrants, the “Warrants”) in connection with,
or following the consummation by the Company of, a Business Combination (defined below), which Post IPO Warrants may be sold and issued
to third party investors and the Company’s Sponsor, officers, directors, initial stockholders and their affiliates in one or more
private placement offerings exempt from registration under the securities Act of 1933, as amended; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with
the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; and

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and
countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding, and legal obligations of the Company, and
to authorize the execution and delivery of this Agreement.

 

    	 

     

    

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants,
and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set
forth in this Agreement.

 

2.
Warrants.

 

2.1.
Form of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto,
the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board
of Directors or Chief Executive Officer and Treasurer, Secretary or Assistant Secretary of the Company and shall bear a facsimile of
the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve
in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he
or she had not ceased to be such at the date of issuance.

 

2.2.
Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant, or portion thereof, may be issued as part
of, and be represented by, a Unit, and any Warrant may be issued in uncertificated or book-entry form through the Warrant Agent and/or
the facilities of The Depository Trust Company (the “Depositary”) or other book-entry depositary system, in each case
as determined by the Board of Directors of the Company or by an authorized committee thereof. Any Warrant so issued shall have the same
terms, force and effect as a certificated Warrant that has been duly countersigned by the Warrant Agent in accordance with the terms
of this Agreement.

 

2.3.
Effect of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned
by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.4.
Registration.

 

2.4.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and
register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions
delivered to the Warrant Agent by the Company.

 

2.4.2.
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may
deem and treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing
on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and
for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.5.
Detachability of Warrants. The securities comprising the Units will not be separately transferable until the 52nd day
following the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which
banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding
Business Day following such date, or earlier with the consent of EF Hutton, a division of Benchmark Investments, LLC (the “Representatives”),
but in no event will the Representatives allow separate trading of the securities comprising the Units until (i) the Company has filed
a Current Report on Form 8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the
Public Offering including the proceeds received by the Company from the exercise of the underwriters’ over-allotment option in
the Public Offering, if the over-allotment option is exercised prior to the filing of the Form 8-K, and (ii) the Company has issued a
press release and has filed a Current Report on Form 8-K announcing when such separate trading shall begin (the “Detachment
Date”).

 

2.6.
Private Warrant and Working Capital Warrant Attributes. The Private Warrants and Working Capital Warrants will be identical to
the Public Warrants.

 

2.7.
Post IPO Warrants. The Post IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public
Warrants except as may be agreed upon by the Company.

 

    	 

     

    

 

3.
Terms and Exercise of Warrants

 

3.1.
Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent (except with respect to uncertificated Warrants), entitle
the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number
of Shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence
of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to the price per share at which the Shares
may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior
to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days; provided, that the Company shall provide
at least twenty (20) days’ prior written notice of such reduction to registered holders of the Warrants and, provided further that
any such reduction shall be applied consistently to all of the Warrants.

 

3.2.
Duration of Warrants. A Warrant may be exercised only during the period commencing 30 days after the consummation by the Company
of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination
with one or more businesses or entities (“Business Combination”) (as described more fully in the Registration Statement),
and terminating at 5:00 p.m., New York City time on the earlier to occur of (i) the date that is five (5) years after the date on which
the Company consummates a Business Combination, (ii) at 5:00 p.m., New York City time on the Redemption Date as provided in Section 6.2
of this Agreement and (iii) the liquidation of the Trust Account (defined below) (“Expiration Date”). The period of
time from the date the Warrants will first become exercisable until the expiration of the Warrants shall hereafter be referred to as
the “Exercise Period.” Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder),
as applicable, each outstanding Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and
all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration Date. The Company in its sole
discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that the Company will provide
at least twenty (20) days’ prior written notice of any such extension to registered holders and, provided further that any such
extension shall be applied consistently to all of the Warrants. Notwithstanding anything to the contrary contained herein, for so long
as any Private Placement Warrant is held by EF Hutton, a division of Benchmark Investments, LLC and/or their designees, such Private
Placement Warrant may not be exercised after five (5) years from the effective date of the Registration Statement.

 

3.3.
Exercise of Warrants.

 

3.3.1.
Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may
be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant, duly
executed, and by paying in full the Warrant Price for each Ordinary Share as to which the Warrant is exercised and any and all applicable
taxes due in connection with the exercise of the Warrant, as follows:

 

(a)
in lawful money of the United States, by good certified check or good bank draft payable to the order of the Warrant Agent or wire transfer;

 

(b)
in the event of a redemption pursuant to Section 6.1 hereof in which the Company’s management has elected to force all holders
of Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of Shares equal
to the quotient obtained by dividing (x) the product of the number of Shares underlying the Warrants, multiplied by the difference between
the Warrant Price and the “Fair Market Value” (defined below) by (y) the Fair Market Value. Solely for purposes of this Section
3.3.1(b), the “Fair Market Value” shall mean the average reported closing price of the Shares for the ten (10) trading days
ending on the third trading day prior to the date on which the notice of redemption is sent to holders of the Warrants pursuant to Section
6 hereof; or

 

(c)
in the event the registration statement required by Section 7.4 hereof is not effective and current within ninety (90) days after the
closing of a Business Combination, by surrendering such Warrants for that number of Shares equal to the quotient obtained by dividing
(x) the product of the number of Shares underlying the Warrants, multiplied by the difference between the exercise price of the Warrants
and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted
unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section 3.3.1(c), the “Fair
Market Value” shall mean the average reported last sale price of the Shares for the ten (10) trading days ending on the trading
day prior to the date of exercise.

 

    	 

     

    

 

3.3.2.
Issuance of Shares. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the
Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates, or book entry
position, for the number of Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her
or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant, or book entry position, for the number
of shares as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, in no event will the Company be required
to net cash settle the Warrant exercise. No Warrant shall be exercisable for cash and the Company shall not be obligated to issue Shares
upon exercise of a Warrant unless the Shares issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt
under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the condition in the
immediately preceding sentence is not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise
such Warrant for cash and such Warrant may have no value and expire worthless, in which case the purchaser of a Unit containing such
Warrants shall have paid the full purchase price for the Unit solely for the Shares underlying such Unit. Warrants may not be exercised
by, or securities issued to, any registered holder in any state in which such exercise or issuance would be unlawful.

 

3.3.3.
Valid Issuance. All Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued,
fully paid and nonassessable.

 

3.3.4.
Date of Issuance. Each person in whose name any book entry position or certificate for Shares is issued shall for all purposes
be deemed to have become the holder of record of such shares on the date on which the Warrant, or book entry position representing such
Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except
that, if the date of such surrender and payment is a date when the share transfer books of the Company or book entry system of the Warrant
Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding
date on which the share transfer books or book entry system are open.

 

3.3.5
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes
such election. If the election is made by a holder, the Warrant Agent shall not cause the exercise of the holder’s Warrant, and
such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together
with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (the “Maximum
Percentage”) of the Shares outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence,
the aggregate number of Shares beneficially owned by such person and its affiliates shall include the number of Shares issuable upon
exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude Shares that would be
issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates
and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by
such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject
to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence,
for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding
Shares, the holder may rely on the number of outstanding Shares as reflected in (1) the Company’s most recent annual report on
Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the SEC as the case may be, (2) a more
recent public announcement by the Company or (3) any other notice by the Company or the Warrant Agent setting forth the number of Shares
outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business
Days, confirm orally and in writing to such holder the number of Shares then outstanding. In any case, the number of outstanding Shares
shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates
since the date as of which such number of outstanding Shares was reported. By written notice to the Company, the holder of a Warrant
may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such
notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered
to the Company.

 

4.
Adjustments.

 

4.1.
Stock Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding
Shares is increased by a stock dividend payable in Shares, or by a split up of Shares, or other similar event, then, on the effective
date of such stock dividend, split up or similar event, the number of Shares issuable on exercise of each Warrant shall be increased
in proportion to such increase in outstanding Shares.

 

    	 

     

    

 

4.2.
Aggregation of Shares. If after the date hereof, the number of outstanding Shares is decreased by a consolidation, combination,
reverse stock split or reclassification of Shares or other similar event, then, on the effective date of such consolidation, combination,
reverse stock split, reclassification or similar event, the number of Shares issuable on exercise of each Warrant shall be decreased
in proportion to such decrease in outstanding Shares.

 

4.3
Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or
make a distribution in cash, securities or other assets to the holders of the Shares or other shares of the Company’s capital stock
into which the Warrants are convertible (an “Extraordinary Dividend”), then the Warrant Price shall be decreased,
effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market value (as determined
by the Company’s Board of Directors, in good faith) of any securities or other assets paid in respect of such Extraordinary Dividend
divided by all outstanding shares of the Company at such time (whether or not any shareholders waived their right to receive such dividend);
provided, however, that none of the following shall be deemed an Extraordinary Dividend for purposes of this provision: (a) any adjustment
described in subsection 4.1 above, (b) any cash dividends or cash distributions which, when combined on a per share basis with all other
cash dividends and cash distributions paid on the Shares during the 365-day period ending on the date of declaration of such dividend
or distribution does not exceed $0.50 per share (taking into account all of the outstanding shares of the Company at such time (whether
or not any shareholders waived their right to receive such dividend) and as adjusted to appropriately reflect any of the events referred
to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant
Price or to the number of Shares issuable on exercise of each Warrant) but only with respect to the amount of the aggregate cash dividends
or cash distributions equal to or less than $0.50, (c) any payment to satisfy the conversion rights of the holders of the Shares in connection
with a proposed initial Business Combination or certain amendments to the Company’s Amended and Restated Certificate of Incorporation
(as described in the Registration Statement) or (d) any payment in connection with the Company’s liquidation and the distribution
of its assets upon its failure to consummate a Business Combination. Solely for purposes of illustration, if the Company, at a time while
the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 and previously paid an aggregate of $0.40 of cash dividends
and cash distributions on the Shares during the 365-day period ending on the date of declaration of such $0.35 dividend, then the Warrant
Price will be decreased, effectively immediately after the effective date of such $0.35 dividend, by $0.25 (the absolute value of the
difference between $0.75 (the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period, including
such $0.35 dividend) and $0.50 (the greater of (x) $0.50 and (y) the aggregate amount of all cash dividends and cash distributions paid
or made in such 365-day period prior to such $0.35 dividend)). Furthermore, solely for the purposes of illustration, if following the
closing of the Company’s initial Business Combination, there were 75,000,000 shares outstanding and the Company paid a $1.00
dividend to 17,500,000 of such shares (with the remaining 82,500,000 shares waiving their right to receive such dividend), then no adjustment
to the Warrant Price would occur as a $17.5 million dividend payment divided by 75,000,000 shares equals $0.175 per share which
is less than $0.50 per share.

 

4.4
Adjustments in Exercise Price. Whenever the number of Shares purchasable upon the exercise of the Warrants is adjusted, as provided
in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately
prior to such adjustment by a fraction (x) the numerator of which shall be the number of Shares purchasable upon the exercise of the
Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of Shares so purchasable immediately
thereafter.

 

4.5.
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares
(other than a change covered by Section 4.1, 4.2 or 4.3 hereof or that solely affects the par value of the Shares), or in the case of
any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company
is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Shares), or in the
case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially
as an entirety in connection with which the Company is dissolved, the Warrant holders shall thereafter have the right to purchase and
receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the Shares of the Company immediately
theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or
other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon
a dissolution following any such sale or transfer, that the Warrant holder would have received if such Warrant holder had exercised his,
her or its Warrant(s) immediately prior to such event. If any reclassification also results in a change in the Shares covered by Section
4.1, 4.2 or 4.3, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3, 4.4 and this Section 4.5. The provisions of this
Section 4.5 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers.
In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant. Notwithstanding
anything to the contrary herein, in the event of any tender offer for shares of Shares, the offeror shall not make any tender offer for
Warrants if the effect of such offer would be to require the Warrants to be accounted for as liabilities under applicable accounting
principles.

 

    	 

     

    

 

4.6.
Issuance in connection with a Business Combination. If, in connection with a Business Combination, the Company (a) issues additional
Shares or equity-linked securities at an issue price or effective issue price of less than $9.20 per share (with such issue price or
effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such issuance to
the Company’s initial stockholders, or their affiliates, without taking into account any founders’ shares held by them prior
to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions),
and (c) the Fair Market Value (as defined below) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the
nearest cent) to be equal to 115% of the greater of (i) the Fair Market Value or (ii) the price at which the Company issues the Shares
or equity-linked securities, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to
180% of the higher of the Fair Market Value and the price at which the Company issues Shares or equity-linked securities. Solely for
purposes of this Section 4.6, the “Fair Market Value” shall mean the volume weighted average reported trading price
of the Shares for the twenty (20) trading days starting on the trading day prior to the date of the consummation of the Business Combination.

 

4.7
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a
Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from
such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant,
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence
of any event specified in Sections 4.1, 4.2, 4.3, 4.4, 4.5, or 4.6, then, in any such event, the Company shall give written notice to
each Warrant holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date
of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.8.
No Fractional Warrants or Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall
not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of
any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon
such exercise, round up to the nearest whole number of Shares to be issued to the Warrant holder.

 

4.9.
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant
to this Agreement. However, the Company may at any time in its sole discretion make any change in the form of Warrant that the Company
may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange
or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.10
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an
adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall
appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall
give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent
and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment. The Company shall
adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

 

5.
Transfer and Exchange of Warrants.

 

5.1.
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the
Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures, in the case of certificated Warrants,
properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal
aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated
Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

    	 

     

    

 

5.2.
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, either in certificated form or in book
entry position, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor
one or more new Warrants, or book entry positions, as requested by the registered holder of the Warrants so surrendered, representing
an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3.
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result
in the issuance of a warrant certificate or book-entry position for a fraction of a Warrant.

 

5.4.
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5.
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with
the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

5.6.
Private Warrants and Working Capital Warrants. The Warrant Agent shall not register any transfer of Private Warrants or Working
Capital Warrants until after the consummation by the Company of an initial Business Combination, except for transfers (i) among the initial
shareholders or to the initial shareholders’ or the Company’s officers, directors, consultants or their affiliates, (ii)
to a holder’s shareholders or members upon the holder’s liquidation, in each case if the holder is an entity, (iii) by bona
fide gift to a member of the holder’s immediate family or to a trust, the beneficiary of which is the holder or a member of the
holder’s immediate family, in each case for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon
death, (v) pursuant to a qualified domestic relations order, (vi) to the Company for no value for cancellation in connection with the
consummation of a Business Combination, (vii) in connection with the consummation of a Business Combination by private sales at prices
no greater than the price at which the Private Warrants were originally purchased, (viii) in the event of the Company’s liquidation
prior to its consummation of an initial Business Combination or (ix) in the event that, subsequent to the consummation of an initial
Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction which results in all of
the Company’s shareholders having the right to exchange their Shares for cash, securities or other property, in each case (except
for clauses (vi), (viii) or (ix) or with the Company’s prior written consent) on the condition that prior to such registration
for transfer, the Warrant Agent shall be presented with written documentation pursuant to which each transferee (each, a “Permitted
Transferee”) or the trustee or legal guardian for such transferee agrees to be bound by the transfer restrictions contained
in this section and any other applicable agreement the transferor is bound by.

 

5.7.
Transfers prior to Detachment. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together
with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange
of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants
included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.7 shall have no effect on any transfer of Warrants
on or after the Detachment Date.

 

6.
Redemption.

 

6.1.
Redemption. Not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the
Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption
Price”), provided that the closing price of the Ordinary equals or exceeds $18.00 per share (subject to adjustment in accordance
with Section 4 hereof), on each of twenty (20) trading days within any thirty (30) trading day period commencing after the Warrants become
exercisable and ending on the third trading day prior to the date on which notice of redemption is given and provided that there is an
effective registration statement covering the Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto,
available throughout the 30-day redemption or the Company has elected to require the exercise of the Warrants on a “cashless basis”
pursuant to subsection 3.3.1(b); provided, however, that if and when the Warrants become redeemable by the Company, the Company may not
exercise such redemption right if the issuance of Shares upon exercise of the Warrants is not exempt from registration or qualification
under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

    	 

     

    

 

6.2.
Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are subject
to redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall
be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date to the registered
holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the
manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

 

6.3.
Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance
with Section 3 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2
hereof and prior to the Redemption Date. In the event the Company determines to require all holders of Warrants to exercise their Warrants
on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information necessary to calculate
the number of Shares to be received upon exercise of the Warrants, including the “Fair Market Value” in such case. On and
after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants,
the Redemption Price.

 

7.
Other Provisions Relating to Rights of Holders of Warrants.

 

7.1.
No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the
Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote
or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of the Company
or any other matter.

 

7.2.
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant
Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated,
or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3.
Reservation of Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Shares
that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4.
Registration of Shares. The Company agrees that as soon as practicable after the closing of its initial Business Combination,
it shall use its best efforts to file as soon as practicable, but in no event later than 45 business days after the closing of our initial
business combination, with the Securities and Exchange Commission a registration statement for the registration, under the Act, of the
Shares issuable upon exercise of the Warrants, and it shall use its best efforts to take such action as is necessary to register or qualify
for sale, in those states in which the Warrants were initially offered by the Company and in those states where holders of Warrants then
reside, the Shares issuable upon exercise of the Warrants, to the extent an exemption is not available. The Company will use its best
efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus
relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration
statement has not been declared effective by the 90th day following the closing of the Business Combination, holders of the Warrants
shall have the right, during the period beginning on the 91st day after the closing of the Business Combination and ending upon such
registration statement being declared effective by the Securities and Exchange Commission, and during any other period when the Company
shall fail to have maintained an effective registration statement covering the Shares issuable upon exercise of the Warrants, to exercise
such Warrants on a “cashless basis” as determined in accordance with Section 3.3.1(c). The Company shall provide the Warrant
Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i)
the exercise of the Warrants on a cashless basis in accordance with this Section 7.4 is not required to be registered under the Act and
(ii) the Shares issued upon such exercise will be freely tradable under U.S. federal securities laws by anyone who is not an affiliate
(as such term is defined in Rule 144 under the Act) of the Company and, accordingly, will not be required to bear a restrictive legend.
For the avoidance of any doubt, unless and until all of the Warrants have been exercised on a cashless basis, the Company shall continue
to be obligated to comply with its registration obligations under the first three sentences of this Section 7.4. The provisions of this
Section 7.4 may not be modified, amended, or deleted without the prior written consent of the Representatives.

 

    	 

     

    

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1.
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Shares upon the exercise of Warrants, but the Company shall not be obligated
to pay any transfer taxes in respect of the Warrants or such Shares.

 

8.2.
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1.
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company.
If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant
(who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme
Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost.
Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the
laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed;
but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of
the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant
Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
rights, immunities, duties, and obligations.

 

8.2.2.
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the Shares not later than the effective date of any such appointment.

 

8.2.3.
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant
Agent under this Agreement without any further act.

 

8.3.
Fees and Expenses of Warrant Agent.

 

8.3.1.
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of
its duties hereunder.

 

8.3.2.
Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the
carrying out or performing of the provisions of this Agreement.

 

8.4.
Liability of Warrant Agent.

 

8.4.1.
Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
and established by a statement signed by the Chief Executive Officer or Chairman of the Board of Directors of the Company and delivered
to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to
the provisions of this Agreement.

 

    	 

     

    

 

8.4.2.
Indemnity. The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and
reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the
Warrant Agent’s fraud, gross negligence, willful misconduct, or bad faith.

 

8.4.3.
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the
validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required
under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining
of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation
or warranty as to the authorization or reservation of any Shares to be issued pursuant to this Agreement, the Amended and Restated Memorandum
and Articles of Association of the Company, or any Warrant or as to whether any Shares will, when issued, be valid and fully paid and
nonassessable.

 

8.5.
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same
upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants
exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Shares through
the exercise of Warrants.

 

9.
Miscellaneous Provisions.

 

9.1.
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall
bind and inure to the benefit of their respective successors and assigns.

 

9.2.
Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder
of any Warrant to or on the Company shall be sufficiently given (i) if by email when the email is sent, (ii) if by hand or overnight
delivery, when so delivered, or (iii) if sent by certified mail or private courier service within five (5) days after deposit of such
notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

 

Genesis
Unicorn Capital Corp..

 Adeoye
Olukotun,  CEO

281
Witherspoon Street,

Suite
120

Princeton,
NJ, 08540

E-mail:
oyeolukotunmd@gmail.com 

 

Any
notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on
the Warrant Agent shall be sufficiently given (i) if by email, when the email is sent, (ii) if by hand or overnight delivery, when so
delivered, or (iii) if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid,
addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental
Stock Transfer & Trust Company

1
State Street

New
York, New York 10004

Attn:
Compliance Department

 

with
a copy in each case to:

 

Becker
& Poliakoff LLP

45
Broadway, 17th Floor

New
York, New York 10006

New
York, NY 10006

Attn:
Brian C. Daughney, Esq.

E-mail:
bdaughney@beckerlawyers.com

 

    	 

     

    

 

and

 

EF
Hutton

c/o
Benchmark Investments, LLC

___________________________

 

___________________________

 

David
Crandall, Esq.

Hogan
Lovells US LLP

1601
Wewatta Street, Suite 900

Denver,
Colorado 80202

E-Mail:
david.crandall@hoganlovells.com

 

9.3.
Applicable Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects
by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the
substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or
relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York. The Company hereby waives any objection that such courts represent an inconvenient forum.
Notwithstanding the foregoing, this exclusive forum provision shall not apply to suits brought to enforce a duty or liability created
by the Securities and Exchange Act of 1934 (“Exchange Act”), any other claim for which the federal courts have exclusive
jurisdiction or any complaint asserting a cause of action arising under the Securities Act against us or any of our directors, officers,
other employees or agents. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any
duty or liability created by the Exchange Act or the rules and regulations thereunder. Any such process or summons to be served upon
the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid,
addressed to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed personal service and shall be legal and
binding upon the Company in any action, proceeding or claim.

 

9.4.
Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the
provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto
and the registered holders of the Warrants and, for the purposes of Sections 7.4, 9.4 and 9.8 hereof, the Representatives, any right,
remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement hereof.
The Representatives shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 7.4, 9.4 and 9.8 hereof.
All covenants, conditions, stipulations, promises, and agreements contained in this Warrant Agreement shall be for the sole and exclusive
benefit of the parties hereto (and the Representatives with respect to the Sections 7.4, 9.4 and 9.8 hereof) and their successors and
assigns and of the registered holders of the Warrants.

 

9.5.
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the
Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant
Agent may require any such holder to submit his Warrant for inspection by it.

 

9.6.
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7.
Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect
the interpretation thereof.

 

9.8
Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of
curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other
provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that
the parties deem shall not adversely affect the interest of the registered holders. All other modifications or amendments, including
any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the written consent or vote of the registered
holders of (i) a majority of the then outstanding Public Warrants if such modification or amendment is being undertaken prior to, or
in connection with, the consummation of a Business Combination or (ii) a majority of the then outstanding Warrants if such modification
or amendment is being undertaken after the consummation of a Business Combination. Notwithstanding the foregoing, the Company may lower
the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of
the registered holders. The provisions of this Section 9.8 may not be modified, amended or deleted without the prior written consent
of the Representatives.

 

9.9
Trust Account Waiver. The Warrant Agent acknowledges and agrees that it shall not make any claims or proceed against the trust
account established by the Company in connection with the Public Offering (as more fully described in the Registration Statement) (“Trust
Account”), including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.
In the event that the Warrant Agent has a claim against the Company under this Agreement, the Warrant Agent will pursue such claim solely
against the Company and not against the property held in the Trust Account.

 

9.10
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof
shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[signature
page follows]

 

    	 

     

    

 

GENESIS
UNICORN CAPITAL CORP.

WARRANT
AGREEMENT

SIGNATURE
PAGE

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	GENESIS
    UNICORN CAPITAL CORP.
	 	 	 
	 	By:	 
	 	Name:	 Adeoye
    Olukotun 
	 	Title:	 Chief Executive Officer
	 	 
	 	CONTINENTAL
    STOCK TRANSFER & TRUST COMPANY
	 	 	 
	 	By:	 
	 	Name:	
	 	Title:	

 

[Signature
Page to Warrant Agreement]

 

    	 

     

    

 

EXHIBIT
A

 

WARRANT
CERTIFICATE

 

    	 

    	 

    

 

EXHIBIT
B

 

LEGEND
FOR PRIVATE PLACEMENT WARRANTS

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES
LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS
ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG GENESIS UNICORN CAPITAL CORP. (THE “COMPANY”), EF
HUTTON AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE
THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF
THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 5.6 OF THE WARRANT AGREEMENT) WHO AGREES
IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES
EVIDENCED BY THIS CERTIFICATE AND SHARES OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS
UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]